![Jing Qiang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 31/08/2026
Jing Qiang is currently Chairman at Suzhou Sinovent Pharmaceutical Technology Co. Ltd., Chairman at Evopoint Bioscience Co., Ltd. since 2018, and Managing Partner at Apricot Capital LLC.
Former roles include Non-Executive Director at Sinomab Bioscience Ltd. from 2020 to 2021, Managing Director at China International Capital Corp.
Ltd. from 2010 to 2018, and Research Analyst at China International Capital Corp.
Ltd. (Broker).
Education includes an undergraduate degree from Shanghai Jiao Tong University in 2005 and a graduate degree from Fudan University in 2010.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SINOMAB BIOSCIENCE LTD. 0,72 % | 16/10/2025 | 9.998.800 ( 0,72 % ) | 1 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Suzhou Sinovent Pharmaceutical Technology Co. Ltd.
 Suzhou Sinovent Pharmaceutical Technology Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, production and commercialization of therapeutic drugs | Presidente | - |
Suzhou Xinnuowei Pharmaceutical Technology Co., Ltd. (China)
 Suzhou Xinnuowei Pharmaceutical Technology Co., Ltd. (China) BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutic drugs | Presidente | 01/04/2018 |
Apricot Capital LLC
 Apricot Capital LLC Investment ManagersFinance Apricot Capital seeks investment opportunities in companies located in the United States and Canada. The firm focuses on the technology sectors. It provides financing for seed and early stage capital requirements. | Inversor de Capital Privado | - |
| Empresas | Cargo | Fin |
|---|---|---|
| SINOMAB BIOSCIENCE LIMITED | Presidente | 30/11/2020 |
| CHINA INTERNATIONAL CAPITAL CORPORATION LIMITED | Director Ejecutivo | 01/03/2018 |
China International Capital Corp. Ltd. (Broker)
 China International Capital Corp. Ltd. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
China International Capital Corp. Ltd. (Broker)
China International Capital Corp. Ltd. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Shanghai Jiao Tong University
 Shanghai Jiao Tong University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fudan University
 Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apricot Capital LLC
Apricot Capital LLC Investment ManagersFinance Apricot Capital seeks investment opportunities in companies located in the United States and Canada. The firm focuses on the technology sectors. It provides financing for seed and early stage capital requirements. | Finance |
Sinomab Bioscience Ltd.
 Sinomab Bioscience Ltd. BiotechnologyHealth Technology Manufactures and distributes antibodies | Health Technology |
China International Capital Corp. Ltd.
 China International Capital Corp. Ltd. Investment Banks/BrokersFinance Provides investment banking, equity brokerage and asset management services | Finance |
Suzhou Sinovent Pharmaceutical Technology Co. Ltd.
Suzhou Sinovent Pharmaceutical Technology Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, production and commercialization of therapeutic drugs | Commercial Services |
Suzhou Xinnuowei Pharmaceutical Technology Co., Ltd. (China)
Suzhou Xinnuowei Pharmaceutical Technology Co., Ltd. (China) BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutic drugs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
